• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·688607.SS
Share

CareRay Digital Medical Technology Co., Ltd. Stocks

CN¥ 38.94Last Updated 18.09.2026

Issuer Rating

2/7
Performance

Poor

Risk

Moderate

Recommendation

Sell

Market Cap

CN¥ 488.72M

CN¥ 38.94
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CareRay Digital Medical Technology Co., Ltd. is a specialist in the development and manufacturing of sophisticated digital X-ray flat panel detectors. Their extensive product line includes cable-free, tethered, and real-time imaging detectors, as well as specialized panels for mammography and industrial inspection. Additionally, the company provides vital accessories and protective tablet enclosures. These advanced imaging solutions are applied across diverse sectors such as human healthcare, veterinary medicine, security screening, and industrial quality control. Founded in 2007, CareRay's operations are headquartered in Suzhou, China.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.09.2026 17:00

Diversification Is an Illusion: How Does "Smart Money" Invest in a Market Dominated by AI?

21.09.2026 16:50

Shares of three micro-cap companies with projects in Greenland have skyrocketed. Trump drove up their prices.

21.09.2026 16:22

AI 'in most cases' gives incorrect answers to financial questions, study finds

21.09.2026 15:37

Morning in New York: Optimism Drives Market Prices

21.09.2026 14:53

German stocks rose despite the chancellor's party's poor showing in the election. What's going on?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026